Inventor

Sharadha Subramanian

Inventor
San Ramon, CA, US

Overview

26→
Patents
2002–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 26 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes15%
C04BLime, magnesia5%
C07BGeneral methods of organic chemistry4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
PatentTitleYear
10,709,712Biaryl amide compounds as kinase inhibitors202010,392,404Compounds and compositions as kinase inhibitors201910,245,267Biaryl amide compounds as kinase inhibitors201910,167,279Compounds and compositions as RAF kinase inhibitors20199,694,016'Biaryl amide compounds as kinase inhibitors'20179,546,173'Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors'20178,735,599'Substituted imidazole derivates'20148,614,330'Substituted benz-azoles and methods of their use as inhibitors of RAF kinase'20138,592,459'Substituted benzimidazoles and methods of their use'20138,415,382'Substituted benzazoles and methods of their use as inhibitors of RAF Kinase'20138,318,791'Substituted imidazole derivatives'20128,299,108'Substituted benzazoles and methods of their use as inhibitors of raf kinase'20127,932,262'Quinazolines for PDK1 inhibition'20117,732,465'Substituted benzimidazoles and methods of their use'20107,728,010'Substituted benz-azoles and methods of their use as inhibitors of Raf kinase'20107,691,866'2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of Raf kinase'20107,671,049'Pyrrole based inhibitors of glycogen synthase kinase 3'20107,626,040'Substituted imidazole compounds as KSP inhibitors'20097,576,221'Substituted imidazole derivatives'20097,482,367'Substituted benzimidazoles and methods of their use'20097,423,150'Substituted benzazoles and methods of their use as inhibitors of Raf kinase'20087,250,443'Pyrrole based inhibitors of glycogen synthase kinase 3'20077,071,216'Substituted benz-azoles and methods of their use as inhibitors of Raf kinase'20067,037,918'Inhibitors of glycogen synthase kinase 3'20066,989,382'Carbocycle based inhibitors of glycogen synthase kinase 3'20066,489,344'Inhibitors of glycogen synthase kinase 3'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2020Based in San Ramon, CA, US· patent location history
2008–2020Patents assigned to NOVARTIS AG (10)· patent assignee history
2009–2014Patents assigned to NOVARTIS VACCINES & DIAGNOSTIC (11)· patent assignee history
2009–2019Based in Emeryville, CA, US· patent location history
2012–2017Patents assigned to RAMURTHY SAVITHRI (7)· patent assignee history
2012–2017Patents assigned to SUBRAMANIAN SHARADHA (7)· patent assignee history
2012–2014Patents assigned to RENHOWE PAUL A (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS VACCINES & DIAGNOSTIC112009–2014
NOVARTIS AG102008–2020
RAMURTHY SAVITHRI72012–2017
SUBRAMANIAN SHARADHAself72012–2017
RENHOWE PAUL A62012–2014
Locations
LocationPatentsSpan
San Ramon, California, US222002–2020
Emeryville, California, US42009–2019